| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06477549 | BeFluBu vs FluBuRux Conditioning in Haploidentical HCT | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06508099 | Vitamin A and D Supplementation in Allogeneic HCT | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06532084 | Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen | Acute Myeloid Leukemia, in Relapse | Recruiting |
| NCT07238712 | Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT07234487 | Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL | Hodgkin Lymphoma | Recruiting |
| NCT06812858 | PD-1 Inhibitors Maintenance for cHL Post-autoHCT | Hodgkin Lymphoma | Recruiting |
| NCT06931613 | Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory… | Relapsed or Refractory Hodgkin Lymphoma | Enrolling by Invitation |
| Phase 1/2 | |||
| NCT06871007 | Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Enrolling by Invitation |
| Phase 1 | |||
| NCT05832515 | AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With… | Multiple Sclerosis | Recruiting |
| Not specified | |||
| NCT04595929 | Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in… | Peritoneal Carcinomatosis | Recruiting |
| NCT07074951 | Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy | Primary IgA-nephropathy | Recruiting |
| NCT07548866 | Comparison of Laryngeal Mask and Tracheal Intubation With and Without Topical Lidocaine… | Comparison of Airway Management Techniques in Functional Endoscopic Sinus Surgery | Active, Not Recruiting |
| NCT07597785 | AI-Assisted Implant Planning Using CBCT Data | Edentulism in Lower Jaw | Active, Not Recruiting |